Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer
Status:
Withdrawn
Trial end date:
2013-02-08
Target enrollment:
Participant gender:
Summary
This phase I trial studies the side effects and best dose of sirolimus and gold sodium
thiomalate when given together in treating patients with advanced squamous non-small cell
lung cancer (NSCLC). Sirolimus and gold sodium thiomalate may stop the growth of tumor cells
by blocking some of the enzymes needed for cell growth